Dr Dafang Zhong, director of Shanghai Center for Drug Metabolism and Pharmacokinetics Research at the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, shares his professional career within the DMPK space, as well as the important work that the Center has done in contributing to the growth and development of the nascent Chinese innovative pharmaceutical industry, having worked on around half of all locally-developed innovative drugs launched in China!
In 2007, we worked on only six innovative compounds. Since 2015, however, we have worked on over 20 innovative drug compounds every year
